The Opening of Biotech

RockinRobStar writes "ABC Science have posted an article about an Australian geneticist, Dr Richard Jefferson, pushing for "free access to the scientific tools of modern biology and genetics...just as computer programming tools were shared in the open source software movement." "The scientific tools...would be licensed under a similar agreement as the general public licence". Dr Jefferson plans to present his program to the World Economic Forum in January."

Comments

Unintended Consequences: Less New Medicine

[G4from128k]

Open access to biotechnology may have unintended consequences that reduce the utility of the biotech knowledge. As much as people hate patents, they do serve a purpose. Giving someone a monopoly right to sell something gives them the incentive to spend money on development. Drug development is hideously expensive -- without some hope of a billion dollar blockbuster payoff, companies aren't going to invest anything in open-access pharmaceuticals.

Now if we could convince goverments to spend money on all aspects of pharma development, we might be OK. Unfortunately, I'd bet that the funding government would get cranky when other countries freely exploit the medicines that the one government paid for. Citizens of countries that fund pharma R&D might reasonably object to shouldering all the burden of developing new medicines for the whole world. Does anyone think the UN would be an effective body for funding the rapid development of new drugs?

Finally, patents are a form of open access (at least in the U.S.). Patents force companies to publish their inventions. This gives competitors a leg up in innovating around any new patented process. Its not as open as the proposed Biological Innovation for Open Society (BIOS) program, but the current system is not as closed as detractors would have you believe.